Hopital de la Conception-APHM

Marseille 13385

0 studies enrolling now · 8 studies all time

What they study most

Antibody-mediated Rejection, Chronic Hypoparathyroidism, Diffuse Large B-Cell Lymphoma, Diffuse Large B-cell Lymphoma, Endocrine System Diseases, Endogenous Cushing's Syndrome, FSGS, Leukemia, MZL, Marginal Zone Lymphoma, Parathyroid Diseases

Studies at this site

• A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB — Recruiting now
• Subcutaneous Epcoritamab With or Without Lenalidomide as First Line Therapy for Diffuse Large B-Cell Lymphoma — Stopped early
• Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML — Running, not enrolling
• A Phase 3 Trial of Epcoritamab vs Investigator's Choice Chemotherapy in Relapsed/Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL) — Running, not enrolling
• Non-interventional Study on Osilodrostat in Patients With Endogenous Cushing's Syndrome — Running, not enrolling
• Evaluation of the Safety and Efficacy of Eneboparatide (AZP-3601) in Patients With Chronic Hypoparathyroidism — Running, not enrolling
• Clazakizumab for the Treatment of Chronic Active Antibody Mediated Rejection in Kidney Transplant Recipients — Stopped early
• Study of Zanubrutinib (BGB-3111) in Participants With Marginal Zone Lymphoma — Completed